1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning

• Martin Gutierrez,
• Deborah Glass,
• Jee Hyun Park,
• Tania Felizardo,
• Daniel H Fowler

Affiliations

Martin Gutierrez

6Hackensack University Medical Center, -, Hackensack, USA

Deborah Glass

Monash University, Melbourne, Australia

Jee Hyun Park

1Rapa Therapeutics, Rockville, MD, USA

Tania Felizardo

1Rapa Therapeutics, Rockville, MD, USA

Daniel H Fowler

1Rapa Therapeutics, Rockville, MD, USA